Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

2.

High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus.

Uçkay I, Bernard L, Buzzi M, Harbarth S, François P, Huggler E, Ferry T, Schrenzel J, Renzoni A, Vaudaux P, Lew DP.

Antimicrob Agents Chemother. 2012 Mar;56(3):1258-64. doi: 10.1128/AAC.05808-11. Epub 2011 Dec 12.

3.

Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study.

Chang HJ, Hsu PC, Yang CC, Siu LK, Kuo AJ, Chia JH, Wu TL, Huang CT, Lee MH.

J Antimicrob Chemother. 2012 Mar;67(3):736-41. doi: 10.1093/jac/dkr531. Epub 2011 Dec 14.

PMID:
22169187
4.
5.

Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.

Kan LP, Lin JC, Chiu SK, Yeh YC, Lin TY, Yang YS, Wang YC, Wang NC, Yeh KM, Chang FY.

J Microbiol Immunol Infect. 2014 Feb;47(1):15-22. doi: 10.1016/j.jmii.2012.08.015. Epub 2012 Oct 3.

6.

Impact of Molecular Epidemiology and Reduced Susceptibility to Glycopeptides and Daptomycin on Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia.

Lee HY, Chen CL, Liu SY, Yan YS, Chang CJ, Chiu CH.

PLoS One. 2015 Aug 21;10(8):e0136171. doi: 10.1371/journal.pone.0136171. eCollection 2015.

7.

Prevalence of isolates with reduced glycopeptide susceptibility in orthopedic device-related infections due to methicillin-resistant Staphylococcus aureus.

Vaudaux P, Ferry T, Uçkay I, François P, Schrenzel J, Harbarth S, Renzoni A.

Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3367-74. doi: 10.1007/s10096-012-1705-8. Epub 2012 Jul 26.

PMID:
22833247
8.

High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.

Wi YM, Kim JM, Joo EJ, Ha YE, Kang CI, Ko KS, Chung DR, Song JH, Peck KR.

Int J Antimicrob Agents. 2012 Aug;40(2):108-13. doi: 10.1016/j.ijantimicag.2012.04.003. Epub 2012 May 26.

PMID:
22633565
9.

Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.

Lin SH, Liao WH, Lai CC, Liao CH, Tan CK, Wang CY, Huang YT, Hsueh PR.

J Antimicrob Chemother. 2010 Aug;65(8):1792-8. doi: 10.1093/jac/dkq188. Epub 2010 May 28.

PMID:
20511366
10.

Impact of psm-mec in the mobile genetic element on the clinical characteristics and outcome of SCCmec-II methicillin-resistant Staphylococcus aureus bacteraemia in Japan.

Aoyagi T, Kaito C, Sekimizu K, Omae Y, Saito Y, Mao H, Inomata S, Hatta M, Endo S, Kanamori H, Gu Y, Tokuda K, Yano H, Kitagawa M, Kaku M.

Clin Microbiol Infect. 2014 Sep;20(9):912-9. doi: 10.1111/1469-0691.12575. Epub 2014 Mar 6.

11.

Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.

Gasch O, Camoez M, Dominguez MA, Padilla B, Pintado V, Almirante B, Molina J, Lopez-Medrano F, Ruiz E, Martinez JA, Bereciartua E, Rodriguez-Lopez F, Fernandez-Mazarrasa C, Goenaga MA, Benito N, Rodriguez-Baño J, Espejo E, Pujol M; REIPI/GEIH Study Groups.

Clin Microbiol Infect. 2013 Nov;19(11):1049-57. doi: 10.1111/1469-0691.12108. Epub 2013 Jan 17.

12.

Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.

Joo J, Yamaki J, Lou M, Hshieh S, Chu T, Shriner KA, Wong-Beringer A.

Clin Ther. 2013 Jul;35(7):995-1004. doi: 10.1016/j.clinthera.2013.05.018. Epub 2013 Jul 2.

PMID:
23829982
13.

Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients.

Rojas L, Bunsow E, Muñoz P, Cercenado E, Rodríguez-Créixems M, Bouza E.

J Antimicrob Chemother. 2012 Jul;67(7):1760-8. doi: 10.1093/jac/dks128. Epub 2012 May 3.

PMID:
22556382
14.
15.

Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia.

Yeh YC, Yeh KM, Lin TY, Chiu SK, Yang YS, Wang YC, Lin JC.

J Microbiol Immunol Infect. 2012 Jun;45(3):214-20. doi: 10.1016/j.jmii.2011.11.006. Epub 2012 May 7.

16.

Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.

Yoon YK, Kim JY, Park DW, Sohn JW, Kim MJ.

J Antimicrob Chemother. 2010 May;65(5):1015-8. doi: 10.1093/jac/dkq050. Epub 2010 Mar 3.

PMID:
20200036
17.

More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.

Shoji H, Maeda M, Shirakura T, Takuma T, Ugajin K, Fukuchi K, Ishino K, Niki Y.

Int J Antimicrob Agents. 2015 Nov;46(5):532-7. doi: 10.1016/j.ijantimicag.2015.07.013. Epub 2015 Aug 31.

PMID:
26364848
18.

Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence.

Forstner C, Dungl C, Tobudic S, Mitteregger D, Lagler H, Burgmann H.

Clin Microbiol Infect. 2013 Jul;19(7):E291-7. doi: 10.1111/1469-0691.12169. Epub 2013 Mar 13.

19.

Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.

Wang JL, Chen SY, Wang JT, Wu GH, Chiang WC, Hsueh PR, Chen YC, Chang SC.

Clin Infect Dis. 2008 Mar 15;46(6):799-806. doi: 10.1086/527389.

PMID:
18266610
20.

Method-specific performance of vancomycin MIC susceptibility tests in predicting mortality of patients with methicillin-resistant Staphylococcus aureus bacteraemia.

Chen SY, Liao CH, Wang JL, Chiang WC, Lai MS, Chie WC, Chang SC, Hsueh PR.

J Antimicrob Chemother. 2014 Jan;69(1):211-8. doi: 10.1093/jac/dkt340. Epub 2013 Aug 29.

PMID:
23997017

Supplemental Content

Support Center